NYC Cancer Institute — New York, New York

NYC Cancer Institute is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

NYC Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor, Unresectable or Metastatic Melanoma.

Sponsors: CytomX Therapeutics.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYC Cancer Institute?

NYC Cancer Institute has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYC Cancer Institute conducted?

NYC Cancer Institute has 1 clinical trials on record. Their work covers Solid Tumor, Unresectable or Metastatic Melanoma.

Is NYC Cancer Institute accredited by Crixeo Health?

NYC Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYC Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.